<html xmlns="http://www.w3.org/1999/xhtml" lang="en-US"><head><meta charset="UTF-8"><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20G-93 - Oversight committee--Duties--Input.</title><meta name="Generator" content="PowerTools for Open XML"><style>span { white-space: pre-wrap; } p.s414ca41df5fd42c0baa5ef50ef330a17Normal { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s414ca41df5fd42c0baa5ef50ef330a17SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s414ca41df5fd42c0baa5ef50ef330a17CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s414ca41df5fd42c0baa5ef50ef330a17Statute { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s414ca41df5fd42c0baa5ef50ef330a17DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s414ca41df5fd42c0baa5ef50ef330a17StatuteNumber1 { margin-left: 0.75in; text-indent: -0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.s414ca41df5fd42c0baa5ef50ef330a17000000 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s414ca41df5fd42c0baa5ef50ef330a17NoIndent { text-indent: 0.00in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s414ca41df5fd42c0baa5ef50ef330a17DefaultParagraphFont-000001 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s414ca41df5fd42c0baa5ef50ef330a17SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } body { text-decoration-skip-ink: none; } </style><meta name="viewport" content="width=device-width, initial-scale=1"><meta name="twitter:card" content="summary"><meta property="og:title" content="SD 34-20G-93 - Oversight committee--Duties--Input."><meta property="og:description" content="SDLRC Codified Law 34-20G-93 - Oversight committee--Duties--Input."><meta property="og:type" content="website"><meta property="og:url" content="https://sdlegislature.gov/Statutes?Statute=34-20G-93"><meta property="og:image" content="https://lawmakerdocuments.blob.core.usgovcloudapi.net/photos/logoshape.webp"><meta property="og:site_name" content="South Dakota Legislature"></head><body><div><p dir="ltr" class="s414ca41df5fd42c0baa5ef50ef330a17Normal"><a href="https://sdlegislature.gov/Statutes?Statute=34-20G-93" rel="noopener"><span class="s414ca41df5fd42c0baa5ef50ef330a17SENU">34-20G-93</span></a><span xml:space="preserve" class="s414ca41df5fd42c0baa5ef50ef330a17SENU">. </span><span class="s414ca41df5fd42c0baa5ef50ef330a17CL">Oversight committee--Duties--Input.</span></p><p dir="ltr" class="s414ca41df5fd42c0baa5ef50ef330a17Statute"><span class="s414ca41df5fd42c0baa5ef50ef330a17DefaultParagraphFont">The oversight committee shall meet at least two times per year for the purpose of evaluating and making recommendations to the Legislature and the department regarding:</span></p><p dir="ltr" class="s414ca41df5fd42c0baa5ef50ef330a17StatuteNumber1"><span class="s414ca41df5fd42c0baa5ef50ef330a17DefaultParagraphFont">(1)    The ability of qualifying patients in all areas of the state to obtain timely access to high-quality medical cannabis;</span></p><p dir="ltr" class="s414ca41df5fd42c0baa5ef50ef330a17StatuteNumber1"><span class="s414ca41df5fd42c0baa5ef50ef330a17DefaultParagraphFont">(2)    The effectiveness of the dispensaries and cultivation facilities, individually and together, in serving the needs of qualifying patients, including the provision of educational and support services by dispensaries, the reasonableness of their prices, whether they are generating any complaints or security problems, and the sufficiency of the number operating to serve the state's registered qualifying patients;</span></p><p dir="ltr" class="s414ca41df5fd42c0baa5ef50ef330a17StatuteNumber1"><span class="s414ca41df5fd42c0baa5ef50ef330a17DefaultParagraphFont">(3)    The effectiveness of the cannabis testing facilities, including whether a sufficient number are operating;</span></p><p dir="ltr" class="s414ca41df5fd42c0baa5ef50ef330a17StatuteNumber1"><span class="s414ca41df5fd42c0baa5ef50ef330a17DefaultParagraphFont">(4)    The sufficiency of the regulatory and security safeguards contained in this chapter and adopted by the department to ensure that access to and use of cannabis cultivated is provided only to cardholders;</span></p><p dir="ltr" class="s414ca41df5fd42c0baa5ef50ef330a17StatuteNumber1"><span class="s414ca41df5fd42c0baa5ef50ef330a17DefaultParagraphFont">(5)    Any recommended additions or revisions to the department regulations or this chapter, including recommendations relating to security, safe handling, labeling, and nomenclature;</span></p><p dir="ltr" class="s414ca41df5fd42c0baa5ef50ef330a17StatuteNumber1"><span class="s414ca41df5fd42c0baa5ef50ef330a17DefaultParagraphFont">(6)    Any research studies regarding health effects of medical cannabis for patients; and</span></p><p dir="ltr" class="s414ca41df5fd42c0baa5ef50ef330a17StatuteNumber1"><span class="s414ca41df5fd42c0baa5ef50ef330a17DefaultParagraphFont">(7)    Any medical and clinical aspects of the medical cannabis program.</span></p><p dir="ltr" class="s414ca41df5fd42c0baa5ef50ef330a17Statute"><span class="s414ca41df5fd42c0baa5ef50ef330a17DefaultParagraphFont">The oversight committee shall ensure that it seeks relevant input from qualifying patients; designated caregivers; pharmacists; school boards and administrators; parents; municipal representatives; state agencies, including the Department of Health, the South Dakota Division of Criminal Investigation, and the Department of Public Safety; and medical cannabis establishments.</span></p><p dir="ltr" class="s414ca41df5fd42c0baa5ef50ef330a17Normal"><span xml:space="preserve" class="s414ca41df5fd42c0baa5ef50ef330a17000000"> </span></p><p dir="ltr" class="s414ca41df5fd42c0baa5ef50ef330a17NoIndent"><span xml:space="preserve" class="s414ca41df5fd42c0baa5ef50ef330a17DefaultParagraphFont-000001">Source: </span><span class="s414ca41df5fd42c0baa5ef50ef330a17SCL">Initiated Measure No. 26, approved Nov. 3, 2020, eff. Jul. 1, 2021; SL 2023, ch 125, § 3; SL 2023, ch 126, § 1.</span></p></div></body></html>